Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
publish chart | backtests Type: candle | line | advanced    Timeframe: intraday | daily | weekly | monthly
WCRX [NASD]
Warner Chilcott plc
Healthcare | Drug Manufacturers - Other | Ireland
financial highlights | statements
Index- P/E12.88 EPS (ttm)1.60 Insider Own1.39% Shs Outstand250.81M Perf Week8.93%
Market Cap5.17B Forward P/E6.46 EPS next Y3.19 Insider Trans-86.76% Shs Float246.52M Perf Month49.78%
Income403.00M PEG9.54 EPS next Q0.85 Inst Own95.33% Short Float0.94% Perf Quarter44.23%
Sales2.45B P/S2.11 EPS this Y139.09% Inst Trans2.57% Short Ratio0.37 Perf Half Y75.85%
Book/sh-1.93 P/B- EPS next Y-4.78% ROA9.38% Target Price20.53 Perf Year36.76%
Cash/sh1.16 P/C17.82 EPS next 5Y1.35% ROE- 52W Range10.85 - 20.30 Perf YTD71.18%
Dividend0.50 P/FCF8.05 EPS past 5Y69.42% ROI11.83% 52W High1.53% Beta1.08
Dividend %2.43% Quick Ratio0.96 Sales past 5Y23.08% Gross Margin87.04% 52W Low89.95% ATR0.80
Employees2100 Current Ratio1.11 Sales Q/Q-13.43% Oper. Margin20.09% RSI (14)92.56 Volatility4.55% 4.54%
OptionableYes Debt/Eq- EPS Q/Q-0.22% Profit Margin16.46% Rel Volume4.11 Prev Close19.60
ShortableYes LT Debt/Eq- EarningsMay 10 BMO Payout- Avg Volume6.28M Price20.61
Recom1.90 SMA2029.01% SMA5041.46% SMA20056.76% Volume24,530,000 Change5.15%
21-May-13Reiterated Barclays Equal Weight $18 → $20
13-May-13Reiterated Cantor Fitzgerald Buy $19 → $23
12-Apr-13Reiterated Cantor Fitzgerald Buy $18 → $19
11-Feb-13Reiterated UBS Buy $24 → $23
11-Feb-13Reiterated Cantor Fitzgerald Buy $15 → $18
07-Nov-12Upgrade Cantor Fitzgerald Hold → Buy $14 → $15
06-Sep-12Reiterated Cantor Fitzgerald Hold $22 → $14
09-Aug-12Upgrade Needham Hold → Buy $20
01-May-12Reiterated Cantor Fitzgerald Buy $22 → $26
17-Apr-12Initiated Auriga Hold $16
09-Dec-11Initiated Barclays Capital Equal Weight $18
10-Nov-11Reiterated UBS Buy $28 → $24
16-Feb-11Reiterated RBC Capital Mkts Outperform $26 → $28
10-Sep-10Reiterated RBC Capital Mkts Outperform $32 → $24
23-Jul-10Initiated RBC Capital Mkts Outperform $30
17-May-10Upgrade Jefferies Hold → Buy $26.50 → $30
03-Feb-10Initiated Oppenheimer Outperform $33
02-Feb-10Upgrade Caris & Company Average → Buy $30 → $35
28-Jan-10Downgrade Jefferies & Co Buy → Hold $26.50
25-Jan-10Downgrade Caris & Company Buy → Average $30
22-May-13 06:45AM  Kasowitz Benson, Eversheds, Latham: Business of Law at Bloomberg
21-May-13 05:23PM  After the close: Merck's mysterious gain; Warner and Actavis stay up at MarketWatch +5.15%
04:05PM  Actavis Lowers Tax Rate to 17% After Warner Chilcott Deal at Bloomberg
04:00PM  Actavis to Buy Warner Chilcott Zacks
03:31PM  The Deal: Actavis Extends Gains Following Warner Deal at TheStreet
02:43PM  4 Merger and Acquisitions Stock Stories For a Tuesday Appraisal at Wall St. Cheat Sheet
02:09PM  Warner Chilcott Reaches New 52-Week High (WCRX) at TheStreet
02:00PM  A Good Deal For Actavis, But Warner Chilcott Goes A Little Cheap at Investopedia
11:23AM  Actavis: The latest Fortune 500 company to "leave" the U.S. for tax reasons at Fortune
12:01AM  Kasowitz Benson, Eversheds, Latham, Davis:Business of Law at Bloomberg
12:01AM  Actavis Lowers Tax Rate to 17% After Warner Chilcott Deal at Bloomberg
20-May-13 07:07PM  Final Trade: Your First Move for Tuesday, May 21 at CNBC
06:36PM  Actavis buying Warner Chilcott in $8.5B deal AP
06:33PM  Actavis buying Warner Chilcott in $8.5B deal AP
06:32PM  Everyone Wins From This Acquisition at Motley Fool
06:07PM  Actavis, Warner Chilcott Stocks Rise On Merger News at Investor's Business Daily
05:58PM  [video] Fast Money Final Trade at CNBC
05:24PM  Wall Street ends flat on correction worries Reuters
04:34PM  [$$] Actavis Charts New Course With Warner Deal at The Wall Street Journal
04:29PM  Stocks Slip on Concerns Markets Are Overpriced at TheStreet
04:27PM  Stocks End Lower; Dow, S&P Briefly Hit New Highs at CNBC
04:24PM  Stocks End Lower Amid Fed Taper Talk at CNBC
04:22PM  On The Fly: Closing Wrap at theflyonthewall.com
04:17PM  Merger Monday on Wall Street at CNNMoney.com
03:16PM  Despite Large Gains, This Stock Is Still a Buy at Motley Fool
03:08PM  Merger Monday on Wall Street at CNNMoney.com
02:56PM  Mondays Movers: Yahoo gains on bold Tumblr deal at MarketWatch
02:41PM  Daily Wrap: May 20, 2013 at Forbes
02:30PM  [$$] Actavis to Buy Warner Chilcott at The Wall Street Journal
02:27PM  Ireland Welcomes Watson Pharmaceuticals, an American Success at TheStreet
02:21PM  Wall Street hovers near record levels as investors hesitate to jump in Reuters
02:21PM  Actavis to buy Warner Chilcott in $5 billion stock deal Reuters
02:14PM  Stocks Dip Amid Fed Taper Talk; Energy Gains at CNBC
02:12PM  The biggest merger you didn't hear about today at Fortune
02:05PM  Warner Chilcott downgraded to Hold from Buy at Needham theflyonthewall.com
01:53PM  Actavis Execs May Love NJ, But Ireland Has Lower Taxes at Forbes
01:50PM  [$$] Actavis Prepares for Its Next Act at Barrons.com
01:41PM  News Summary: Actavis plans Warner Chilcott deal AP
01:34PM  Stocks Flat; Dow, S&P Briefly Hit Fresh Highs at CNBC
01:32PM  Actavis buying Warner Chilcott in $8.5B deal AP
01:06PM  On The Fly: Midday Wrap at theflyonthewall.com
12:28PM  Yahoo! Pays Big Bucks For Tumblr and 2 Other Hot Stocks to Watch at Wall St. Cheat Sheet
12:04PM  Merger Monday on Wall Street at CNNMoney.com
11:57AM  [video] Dow Dull Except for Deal Stocks at TheStreet
11:54AM  Stocks Gain, Led by Energy; Nasdaq Tops 3500 at CNBC
11:36AM  Actavis to Acquire Warner Chilcott in $8.5 Billion Deal at Motley Fool
11:18AM  Actavis, Warner Chilcott Stocks Rise On Merger News at Investor's Business Daily
11:16AM  Stocks Reverse Early Losses; Nasdaq Tops 3500 at CNBC
11:16AM  [$$] Actavis to Buy Warner Chilcott at The Wall Street Journal
11:15AM  Stocks Edge Higher on Yahoo!, Actavis Deals at TheStreet
11:08AM  Actavis buying Warner Chilcott in $8.5B deal AP
11:06AM  Three Reasons Actavis Is Buying Warner Chilcott at Forbes
11:01AM  Stocks Waver; Nasdaq Crosses Above 3500 at CNBC
10:46AM  Actavis to buy Warner Chilcott in $5 billion stock deal Reuters
10:46AM  Gains in Actavis-Warner Chilcott deal already baked into shares at MarketWatch
10:43AM  Actavis price target rasied to $145 from $124 at BMO Capital theflyonthewall.com
10:39AM  Warner Chilcott Rises On Unusually High Volume (WCRX) at TheStreet
10:32AM  [video] Faber Report: Royalty Pharma to Raise Elan Bid at CNBC
10:19AM  Stocks Edge Higher as Yahoo!, Actavis Strike Deals at TheStreet
10:01AM  The Deal: Actavis Plays Hunter in $8.5 Billion Deal for Ireland's Warner Chilcott at TheStreet
09:44AM  [video] Monday, May 20: Traders Watching Yahoo Carefully at MarketWatch
09:32AM  Stocks Slip at Open as Fed Worries Weigh at CNBC
09:26AM  On The Fly: Pre-market Movers at theflyonthewall.com
09:17AM  Wall Street to dip after records, acquisitions eyed Reuters
09:15AM  [video] Faber Report: Actavis to Buy Warner Chilcott at CNBC
09:14AM  Actavis Uses Surging Stock To Snap Up Warner-Chilcott For $5B Plus Debt at Forbes
09:13AM  Stock Futures Slip as Investors Seek Clarity from Fed at TheStreet
09:13AM  Futures Slip as Investors Seek Fed Clarity at TheStreet
09:12AM  An Undervalued Play in Pharma at Motley Fool
09:05AM  M&A News: Yahoo, Warner Chilcott at Forbes
09:00AM  Announcement Under Irish Takeover Rules Revision to Relevant Securities in Issue GlobeNewswire
08:59AM  Futures Lower Head Of The Bell; Activis Buys Warner Chilcott at Investor's Business Daily
08:48AM  Futures Slide Amid Fed Easing Fears at CNBC
08:46AM  Stock futures flat; Yahoo will buy Tumblr at MarketWatch
08:33AM  Stock futures dip after records, acquisitions eyed Reuters
08:30AM  US STOCKS-Futures dip after records, acquisitions eyed at Reuters
08:27AM  Actavis to buy Warner Chilcott in $5 billion stock deal Reuters
08:26AM  Premarkets: Yahoo in focus as stocks stick near record highs at CNNMoney.com
08:25AM  [video] Yahoo! Deal Kicks off Fed Week at TheStreet
08:22AM  Stock futures flat with Fed speakers on tap at MarketWatch
08:19AM  U.S. Stock Futures Edge Down at The Wall Street Journal
08:09AM  [$$] Actavis to Buy Warner Chilcott at The Wall Street Journal
08:03AM  Actavis to Buy Warner Chilcott in All-Stock Deal at New York Times
08:01AM  Actavis buying Warner Chilcott in $8.5B deal AP
07:57AM  [$$] Actavis to Buy Warner Chilcott at The Wall Street Journal
07:56AM  Stock futures flat with Fed speakers on tap at MarketWatch
07:50AM  Actavis to buy Warner Chilcott in $8.5 billion stock deal Reuters
07:44AM  Stock futures little changed after records, acquisitions eyed Reuters
07:43AM  US STOCKS-Futures little changed after records, acquisitions eyed at Reuters
07:34AM  BRIEF-Warner Chilcott shares up 4.1 percent in premarket trade after Actavis Inc says will buy at Reuters
07:23AM  BRIEF-Actavis shares up 3.8 percent in premarket trade at Reuters
07:20AM  Actavis to buy Warner Chilcott in $8.5 billion deal Reuters
07:16AM  Actavis to buy Warner Chilcott in $8.5 bln deal at Reuters
07:15AM  Actavis Agrees to Buy Warner Chilcott for $8.5 Billion in Stock at Bloomberg
07:06AM  Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company PR Newswire
07:05AM  BRIEF-Actavis says to buy Warner Chilcott for $8.5 bln at Reuters
17-May-13 04:24PM  Actavis Could Lower Tax Rate With Warner Chilcott Deal at The Wall Street Journal
01:12PM  Warner Chilcott buy may be Actavis' best takeover defense at Reuters
01:04PM  WARNER CHILCOTT PLC Financials EDGAR Online Financials
12:57PM  DEALTALK: Warner Chilcott buy may be Actavis' best takeover defense at Reuters
Warner Chilcott Public Limited Company, a specialty pharmaceutical company, engages in the development, manufacture, promotion, and franchise of branded pharmaceutical products focusing on the women's healthcare, gastroenterology, urology, and dermatology markets. Its principal products include ACTONEL for the prevention and treatment of postmenopausal osteoporosis; ATELVIA for the treatment of postmenopausal osteoporosis; LOESTRIN 24 FE and LO LOESTRIN FE, which are oral contraceptives for the prevention of pregnancy; ESTRACE cream, a vaginal cream for the treatment of vaginal and vulvar atrophy; ASACOL for the treatment of ulcerative colitis for orally administered 5-aminosalicylic acid products and maintenance of remission; ASACOL HD for the treatment of active ulcerative colitis; ENABLEX for the treatment of overactive bladder; and DORYX, a tetracycline-class oral antibiotic for the treatment of severe acne. The company markets its products and services through wholesale pharmaceutical distributors, and retail drug store chains. It has collaboration agreement with Sanofi-Aventis U.S. LLC to co-develop and market ACTONEL. The company has operations primarily in the United States, Puerto Rico, the United Kingdom, the Republic of Ireland, Australia, and Canada. Warner Chilcott Public Limited Company was founded in 1968 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.Apr 01Sale13.417039,428144,838Apr 01 04:39 PM
CONNAUGHTON JOHNDirectorMar 04Sale13.4710,590,608142,655,4900Mar 06 05:12 PM
Ellman HermanSenior V.P., Clinical Devel.Mar 01Sale13.381,66622,293181,223Mar 04 04:04 PM
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.Feb 28Sale13.4615,869213,655145,541Mar 01 04:19 PM
Gilligan Claire ASenior V.P., QualityFeb 28Sale13.462,35431,69477,632Mar 01 04:13 PM
Rodriguez Rama FranciscoSenior V.P., Tech. OperationsFeb 28Sale13.4682011,04030,529Mar 01 04:13 PM
Cross Leland HSenior V.P., Tech. OperationsFeb 28Sale13.461,32417,826204,826Mar 01 04:12 PM
Fenton AndrewSenior V.P., CIOFeb 28Sale13.461,39018,715108,310Mar 01 04:11 PM
Halstead MichaelSenior V.P., Corp. DevelopmentFeb 28Sale13.461,74723,52152,206Mar 01 04:10 PM
Howard Alvin DSr. V.P., Regulatory AffairsFeb 28Sale13.461,72823,26599,689Mar 01 04:10 PM
Boissonneault Roger MCEO & PresidentFeb 28Sale13.4618,730252,1752,312,618Mar 01 04:07 PM
Herendeen PaulExec. V.P. and CFOFeb 28Sale13.464,67462,929132,620Mar 01 04:08 PM
Fuhrmann RochelleSenior V.P., FinanceFeb 28Sale13.461,72823,26556,546Mar 01 04:09 PM
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.Feb 27Option Exercise0.0031,7370161,410Mar 01 04:19 PM
Gilligan Claire ASenior V.P., QualityFeb 19Sale14.531,04515,18179,986Feb 21 04:11 PM
Fenton AndrewSenior V.P., CIOFeb 19Sale14.534196,087109,700Feb 21 04:12 PM
Howard Alvin DSr. V.P., Regulatory AffairsFeb 19Sale14.5376711,143101,417Feb 21 04:09 PM
Cross Leland HSenior V.P., Tech. OperationsFeb 19Sale14.535538,034206,150Feb 21 04:10 PM
Ellman HermanSenior V.P., Clinical Devel.Feb 19Sale14.5369110,039182,889Feb 21 04:11 PM
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.Feb 19Sale14.532,56237,220129,673Feb 21 04:07 PM
Fuhrmann RochelleSenior V.P., FinanceFeb 19Sale14.5376711,14358,274Feb 21 04:06 PM
Halstead MichaelSenior V.P., Corp. DevelopmentFeb 19Sale14.534196,08753,953Feb 21 04:05 PM
Boissonneault Roger MCEO & PresidentFeb 19Sale14.537,928115,1762,331,348Feb 21 04:03 PM
Herendeen PaulExec. V.P. and CFOFeb 19Sale14.531,96928,605137,294Feb 21 04:04 PM
Herendeen PaulExec. V.P. and CFOFeb 01Sale14.182,84040,266101,543Feb 04 04:03 PM
Boissonneault Roger MCEO & PresidentFeb 01Sale14.189,125129,3762,222,156Feb 04 04:02 PM
Fenton AndrewSenior V.P., CIOFeb 01Sale14.1899614,12194,649Feb 04 04:12 PM
Ellman HermanSenior V.P., Clinical Devel.Feb 01Sale14.181,01014,320168,110Feb 04 04:11 PM
Cross Leland HSenior V.P., Tech. OperationsFeb 01Sale14.1880811,456191,233Feb 04 04:11 PM
Howard Alvin DSr. V.P., Regulatory AffairsFeb 01Sale14.181,01014,32086,714Feb 04 04:10 PM
Halstead MichaelSenior V.P., Corp. DevelopmentFeb 01Sale14.1899814,15038,902Feb 04 04:10 PM
Gilligan Claire ASenior V.P., QualityFeb 01Sale14.181,37719,52365,561Feb 04 04:09 PM
Fuhrmann RochelleSenior V.P., FinanceFeb 01Sale14.1899814,15043,571Feb 04 04:08 PM
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.Feb 01Sale14.1813,790195,517132,235Feb 04 04:07 PM
Gilligan Claire ASenior V.P., QualityJan 30Sale13.384896,54566,938Jan 31 04:48 PM
Cross Leland HSenior V.P., Tech. OperationsJan 30Sale13.384656,224192,041Jan 31 04:48 PM
Ellman HermanSenior V.P., Clinical Devel.Jan 30Sale13.385867,843169,120Jan 31 04:47 PM
Fenton AndrewSenior V.P., CIOJan 30Sale13.383514,69895,645Jan 31 04:47 PM
Fuhrmann RochelleSenior V.P., FinanceJan 30Sale13.382823,77444,569Jan 31 04:45 PM
Howard Alvin DSr. V.P., Regulatory AffairsJan 30Sale13.385917,91087,724Jan 31 04:46 PM
Halstead MichaelSenior V.P., Corp. DevelopmentJan 30Sale13.383204,28339,900Jan 31 04:45 PM
Herendeen PaulExec. V.P. and CFOJan 30Sale13.382,20829,552104,383Jan 31 04:43 PM
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.Jan 30Sale14.282,21531,621146,025Jan 31 04:44 PM
Boissonneault Roger MCEO & PresidentJan 30Sale13.388,470113,3632,231,281Jan 31 04:43 PM
Fenton AndrewSenior V.P., CIOJan 22Sale13.506218,38395,996Jan 23 04:13 PM
Ellman HermanSenior V.P., Clinical Devel.Jan 22Sale13.501,16615,741169,706Jan 23 04:12 PM
Howard Alvin DSr. V.P., Regulatory AffairsJan 22Sale13.501,22216,49788,315Jan 23 04:10 PM
Gilligan Claire ASenior V.P., QualityJan 22Sale13.5094912,81167,427Jan 23 04:11 PM
Cross Leland HSenior V.P., Tech. OperationsJan 22Sale13.5083911,326192,506Jan 23 04:10 PM
Fuhrmann RochelleSenior V.P., FinanceJan 22Sale13.504886,58844,851Jan 23 04:09 PM
Halstead MichaelSenior V.P., Corp. DevelopmentJan 22Sale13.504886,58840,220Jan 23 04:08 PM
Boissonneault Roger MCEO & PresidentJan 22Sale13.5013,924187,9732,239,751Jan 23 04:06 PM
Herendeen PaulExec. V.P. and CFOJan 22Sale13.504,30558,117106,591Jan 23 04:07 PM
Murray Stephen PDirectorNov 28Sale11.416,491,61874,069,3610Nov 30 03:11 PM
Murray Stephen PDirectorNov 20Sale11.665,000,00058,300,0006,491,618Nov 20 10:47 AM
Gilligan Claire ASenior V.P., QualityOct 01Sale13.552643,57768,376Oct 01 04:41 PM
Halstead MichaelSenior V.P., Corp. DevelopmentOct 01Sale13.55771,04340,708Oct 01 04:40 PM
JPMP MASTER FUND MANAGER L P10% OwnerSep 11Sale13.1028,762,425376,787,76887,216Sep 11 03:45 PM
JP MORGAN PARTNERS BHCA LP10% OwnerSep 11Sale13.1028,762,425376,787,76887,216Sep 11 03:03 PM
Herendeen PaulExec. V.P. and CFOSep 11Sale13.10309,2404,051,044110,896Sep 12 04:10 PM
Hara IzumiSenior V.P.Sep 11Sale13.10126,9931,663,60873,885Sep 12 04:11 PM
Howard Alvin DSr. V.P., Regulatory AffairsSep 11Sale13.10147,6391,934,07189,537Sep 12 04:08 PM
Ellman HermanSenior V.P., Clinical Devel.Sep 11Sale13.1023,500307,850170,872Sep 12 04:07 PM
Murray Stephen PDirectorSep 11Sale13.1014,000,000183,400,00011,491,618Sep 12 10:26 AM
CONNAUGHTON JOHNDirectorSep 11Sale13.1012,890,449168,864,88211,491,622Sep 13 05:29 PM
BAIN CAPITAL INVESTORS LLC10% OwnerSep 11Sale13.1012,890,449168,864,88211,491,622Sep 13 05:29 PM
THL WC (Dutch) B.V.10% OwnerSep 11Sale13.1014,000,000183,400,00011,491,622Sep 13 04:54 PM
ABBRECHT TODD MDirectorSep 11Sale13.1014,000,000183,400,00011,491,622Sep 13 04:53 PM
Halstead MichaelSenior V.P., Corp. DevelopmentJul 02Sale17.963556,37640,785Jul 02 04:30 PM
open in yahoo | open in reuters | open in google